Behandlung von Tumorerkrankungen

European patent · EP2386859 · Deleted

Register entry

Publication number
EP2386859
Application number
EP10184605
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Nov 27, 2001
Published
Nov 16, 2011
Granted
Nov 11, 2015
Deleted
Nov 27, 2021
Reason
Maximum term reached
IPC classes
C07K 16/30 (2006.01)
A61K 39/395 (2006.01)
A61P 35/00 (2006.01)
Priority
US 253361 P 27.11.2000
US 255370 P 13.12.2000
US 256027 P 15.12.2000
US 258157 P 22.12.2000
US 259615 P 03.01.2001
US 260186 P 05.01.2001
US 266169 P 02.02.2001
US 266929 P 06.02.2001
US 278093 P 23.03.2001
US 289444 P 07.05.2001
US 294887 P 31.05.2001
US 298272 P 14.06.2001
Divided from
EP10162600
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Nov 27, 2021

    Maximum term reached

    Published in Swissreg on 27.11.2021

  2. Mar 3, 2016

    Agent entered

    Representative
    MICHELI & CIE SA, 122, Rue de Genève, Case postale 61, 1226 Thônex

    Published in Swissreg on 03.03.2016

  3. Mar 3, 2016

    Address changed

    Owner
    Minerva Biotechnologies Corporation, 142 Church Street, Newton, MA 02458, USA → Minerva Biotechnologies Corporation, 40 Bear Hill Road, Waltham, MA 02451, USA

    Published in Swissreg on 03.03.2016

  4. Nov 11, 2015

    Granted

    Published in Swissreg on 11.11.2015

Parties

Holder

Minerva Biotechnologies Corporation

40 Bear Hill Road, Waltham, MA 02451, US

Agent

MICHELI & CIE SA

122, Rue de Genève Case postale 61, 1226 Thônex

Inventor

Bamdad, Cynthia

Waltham, MA 02451, US

Bamdad, Shoshana

Waltham, MA 02451, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.